Pages that link to "Q38686076"

The following pages link to Use of liposomes as injectable-drug delivery systems (Q38686076):

Displaying 29 items.

• Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis (Q24564481) (← links)
• A functional chimaeric S-layer-enhanced green fluorescent protein to follow the uptake of S-layer-coated liposomes into eukaryotic cells (Q33196837) (← links)
• Distribution of lipid formulations of amphotericin B into bone marrow and fat tissue in rabbits (Q33978764) (← links)
• Liposomal and lipid formulations of amphotericin B. Clinical pharmacokinetics (Q35372178) (← links)
• Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. (Q35516397) (← links)
• Newer antifungal agents (Q35744330) (← links)
• Liposome-incorporated ciprofloxacin in treatment of murine salmonellosis (Q35899686) (← links)
• Optimizing efficacy of amphotericin B through nanomodification (Q36920328) (← links)
• Toward a cure for osteoporosis: reversal of excessive bone fragility (Q36955051) (← links)
• Rapid preparation of giant unilamellar vesicles (Q37253450) (← links)
• Microencapsulation technology by nature: Cell derived extracellular vesicles with therapeutic potential (Q37320015) (← links)
• Pharmacokinetics and buccal mucosal concentrations of a 15 milligram per kilogram of body weight total dose of liposomal amphotericin B administered as a single dose (15 mg/kg), weekly dose (7.5 mg/kg), or daily dose (1 mg/kg) in peripheral stem cel (Q37333175) (← links)
• In vivo biodistribution of a radiolabeled blood substitute: 99mTc-labeled liposome-encapsulated hemoglobin in an anesthetized rabbit (Q37639117) (← links)
• Liposomal bupivacaine: a review of a new bupivacaine formulation (Q38050749) (← links)
• Drug Delivery Systems for Imaging and Therapy of Parkinson's Disease (Q38682342) (← links)
• Liposomes as carriers of antimicrobial agents or immunomodulatory agents in the treatment of infections (Q40899101) (← links)
• Antifungal agents in the 1990s. Current status and future developments (Q40900121) (← links)
• Liposomal formulations of cytotoxic drugs (Q41129856) (← links)
• Effects of route and formulation on clinical pharmacokinetics of interleukin-2. (Q41458688) (← links)
• Strategies for blocking the fibrogenic actions of connective tissue growth factor (CCN2): From pharmacological inhibition in vitro to targeted siRNA therapy in vivo (Q41833192) (← links)
• Acyl chain orientational order in large unilamellar vesicles: comparison with multilamellar liposomes: a 2H and 31P nuclear magnetic resonance study (Q41864601) (← links)
• A modified spectroscopic method for the determination of the transbilayer distribution of phosphatidylethanolamine in soya-bean asolectin small unilamellar vesicles (Q42822805) (← links)
• Spectrofluorimetric determination of second critical micellar concentration of SDS and SDS/Brij 30 systems. (Q46348239) (← links)
• Liposomes: Clinical Applications and Potential for Image-Guided Drug Delivery. (Q49550152) (← links)
• Systematic review and meta-analysis of the efficacy of liposomal bupivacaine in colorectal resections. (Q55519305) (← links)
• Preparation and properties of nanoscale containers for biomedical application in drug delivery: preliminary studies with kynurenic acid (Q60732917) (← links)
• Indium-111-labelled liposomes: dosimetry and tumour detection in patients with cancer (Q70577901) (← links)
• Transmembrane distribution of lipophilic cations in response to an electrochemical potential in reconstituted cytochrome c oxidase vesicles and in vesicles exhibiting a potassium ion diffusion potential (Q72121084) (← links)
• Treatment of systemic candidiasis in a neutropenic murine model using immunoglobulin G bearing liposomal amphotericin B (Q72624132) (← links)